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their derivatives) have been scrutinized as powerful tumor imaging and therapeutic reagents. 20 21 Accordingly, it is significant to develop a high-affinity sdAb targeting pancreatic tumors. 2A3, a sdAb with high affinity against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) was isolated successfully from an immunized llama library. 22 23 2A3 was shown to bind strongly to the BxPC3 human pancreatic cell line cells. The detailed isolation and chartacterization of 2A3 can be found elsewhere. 22 Thus, the combination of sdAb 2A3 for targeting pancreatic tumors that express CEACAM6 and the water dispersed CDTeSe/CdS near-IR QDs appeared to us to be an important target. This manuscript describes the preparation and properties of this combination.
EXPERIMENTAL DETAILS

Synthesis of CdTeSe and CdTeSe/CdS Quantum Dots
This manuscript addresses our targeted optical imaging upon the discovery of specific sdAb-antigen recognition which can lead to the development of optical molecular imaging aiming at the early-stage detection of pancreatic cancer. The contrast agent used was high-quality CdTeSe/CdS QDs exhibiting rich absorption substructures, high quantum yield and narrow emission bandwidth. For the synthesis carried out in the present study, all chemicals used were purchased from Sigma-Aldrich (or otherwise specified) and were used as received. They were cadmium Oxide CdO (99.99%), selenium powder (Se, 99%), tellurium powder (Te, 99%), trioctylphoshpine (TOP, tech. 90%), tri-n-octylphosphine oxide (TOPO, tech. 90%), hexadecylamine (HDA, 90%), 1-octadecene (ODE, 90%), mercaptoundecanoic acid (MUA, 98%), DL-lysine (98%), (1-ethyl-3-[3-dimethylaminopropyl] carbodiimide) (EDC), N,N'-dicyclohexylcarbodiimide (DCC, 99%), tetradecylphosphonic acid (TDPA, 98%, Alfa Aesar), and hexamethyldisilthiane ((TMS) 2 S, Fluka). All reactions were conducted under inert atmosphere using Schlenk techniques. For the synthesis of the CdTeSe QDs via a hot-injection approach, a three-neck round-bottom flask was equipped with a vacuum line and gas inlet, a thermometer and magnetic stirrer; 51.2 mg (0.4 mmol) CdO, 225.0 mg (0.8 mmol) TDPA, 930.0 mg TOPO, 920.0 mg HAD, and 1.4 g TOP were loaded. A SeTOP solution (with 7.4 mg (0.1 mmol) Se and 0.4 g TOP) was sonicated at ∼40 C for 30 min and a TeTOP solution (with 12.8 mg (0.1 mmol) Te and 0.7 g TOP) for 120 min. The two solutions were mixed and then added swiftly into the Cd precursor solution at 300 C. The growth of the CdTeSe QDs was conducted at 270 C for 30 min. The synthesis of the core/shell CdTeSe/CdS QDs was similar to that of our core/shell CdSe/ZnS QDs but with modification. 4 Stock solutions of 0.1 M CdO/TOP and 0.1 M S/TOP were prepared separately and mixed at room temperature before the addition to the CdTeSe core at 140 C. The growth was at ∼155 C for ∼ three hours and then ∼110 C for ∼16 hours.
Conjugation of sdAbs with CdTeSe/CdS QDs
The CdTeSe/CdS QDs were bio-conjugated with sdAbs 2A3 and EG2, with the same chemistry. Scheme 1 outlines the synthesis of the 2A3-QD bio-conjugate. Note that camelid sdAb EG2 was engineered to bind to a tumor marker protein, epidermal growth factor receptor (EGFR). 4 For a typical synthesis, a 500 l QD stock solution (∼10 −4 mmol) was mixed with a 300 l PBS solution consisting of sdAb 2A3 or EG2 (1.5 mg/ml sdAb/PBS); 2A3 or EG2 is estimated to be ∼10 −4 mmol based on a molecular weight of ∼15 K. The bio-conjugation procedure was the known EDC method, (∼10 −3 mmol) of EDC and 20 l( ∼10 −3 mmol) of Nhydroxysuccinimide (NHS) were added at room temperature with vigorous stirring for a maximum of one hour. The EDC stock solution was prepared with 8.1 mg EDC in 100 l distilled water, while the NHS stock solution was prepared with 5.6 mg NHS in 200 l distilled water. The resulting bio-conjugates, un-purified and purified, were used for immunocytochemistry. The purification was carried out with a 30 000 MWCO centrifuge filter device. Therefore, with the feed molar ratio of 1QD : 1sdAb, the purified bio-conjugates should have a molecular weight greater than 30 kDa so they were retained on the filter used.
Cancer Cell Imaging
The specific and compelling targeting of sdAb-conjugated near-IR QDs to cancer cells is demonstrated as proof of principle, with the resulting 2A3-conjugated CdTeSe/CdS QDs on in vitro grown BxPC3 human pancreatic cancer cells, and the resulting EG2-conjugated CdTeSe/CdS QDs on in vitro grown MDA-MB-468 human breast cancer cells. The tumor cell lines were obtained from American Type Culture Collection (ATCC) and cultured in RPMI (Gibco) medium supplemented with 10% fetal bovine serum (Roche) at 37 C, 5% CO 2 in 6 well plates (Falcon) with a sterile cover slip in each well. When the cells were about 70% confluence, they were fixed on the cover 
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CdTeSe/CdS water, Exc 500 nm slips by using 10% formaldehyde in PBS for 10 minutes. The cells were washed with PBS and then incubated with 2% skimmed milk in PBS for 2 hours. After washing with PBS, cells were incubated with the core/shell QDs alone or sdAb-conjugated QDs (purified or unpurified) for one hour and washed three times with PBS. Finally the cover slips were mounted on a microscopic slide using the Prolong Antifade Kit (Molecular Probes) and were imaged under the epifluorescence microscope (IX-81, Olympus) equipped with a 150x, 1.45 NA oil immersion objective lens (UAPON 150XOTIRF, Olympus) and a back-illuminated EMCCD camera (Cascade 512B, Roper Scientific). The near-IR emitters are excellent providing high signal-to-background sensitivity in targeted cellular imaging. Note that the sdAbs 2A3 and EG2 can be used as both targeting and therapeutic reagents. 20 21 To the best of our knowledge, the present work is the first on the targeted imaging of cancer cells with sdAb-conjugated CdTeSe/CdS QDs. QDs. Here, to transfer the core/shell QDs (shown in Fig. 1  (left) ) into aqueous environment, their surface ligands were exchanged with mercaptoundecanoic acid (MUA) and subsequently cross-linked by lysine, 10 11 as shown in Scheme 1. The resulting CdTeSe/CdS QDs with their surface ligands comprising carboxyl groups and amino groups are water-soluble, highly fluorescent, and stable against flocculation. These CdTeSe/CdS QDs in water exhibited a quantum yield of ca. 23% (excited at 500 nm). The sdAbconjugated QDs exhibited relatively low PL efficiency as compared to the non-conjugated QDs in water, but little change in the emission peak position and width (which can be expressed as full width at half maximum (FWHM)). For the water-soluble CdTeSe/CdS QDs (shown in Fig. 1 right Curves 1 and 4), see Figure 2 for a typical Scanning Transmission Electron Microscopy (STEM) image. No significant aggregation was observed under the microscopy, while the corresponding core/shell QD water dispersion, kept at room temperature, exhibited little visible precipitation within 3 months of monitor. Figure 3 shows the no cell control fluorescence images that demonstrate a 10,000x intensity increase versus background.
RESULTS AND DISCUSSION
To target BxPC3 a human pancreatic cancer cell line which over expresses CEACAM6 25 and MDA-MB-468, a human breast cancer cell line which over expresses EGFR, 26 the 2A3-conjugates QDs (shown in Fig. 1 right-2) and EG2-conjugates QDs (shown in Fig. 1 right-3 ) were used for in vitro studies, respectively. The images of the pancreatic and breast cancer cells are shown in Figures 4 and 5 , respectively. The images were recorded with the excitation wavelength of 488 nm; also, bandpass a1 a2 b1 b2 c1 c2 d2 d1 filters either 514-588 nm or 750-822 nm were used for the fluorescence detection. To facilitate intensity comparison, the same laser power, exposure time, and camera settings were used to record; the same brightness and contrast settings were applied to display the images shown in J. Nanosci. Nanotechnol. 11, 1-7, 2011 (Fig. 4(c2) ) shows predominantly low intensity background pixels (below 10000); while in the image of the labelled cells (Fig. 4(a2) ), much higher intensities dominate. The y axis represents mean pixel counts obtained from the corresponding microscopic images. The image of the unlabelled cell ( Fig. 5(c2) ) shows predominantly low intensity background pixels (below ∼10000, right y axis); while in the image of the labelled cell ( Fig. 5(a2) ), much higher intensities (left y axis) are present. The two y axes represent mean pixel counts obtained from the corresponding microscopic images.
conjugated CdTeSe/CdS QDs on the surface of the cancer cells. The intensity difference of the near-IR fluorescence between the labelled (Figs. 4(a2) and 5(a2)) and unlabelled cells (Figs. 4(c2) and 5(c2)) is also evident by examining histograms, as shown in Figures 6 and 7 , respectively. Only the labelled cells show intensities (in gray levels) drastically above the background peak. Similarly in the presence of non-conjugated sdAb the fluorescence intensity is diminished (Figs. 4(d2) and 5(d2)) consistent with targeting by the 2A3-CECAM6 interaction. Thus, our 2A3-conjugated near-IR QDs have great potential to detect CEACAM6 for the early-stage diagnostics of pancreatic cancer. It is noteworthy that the surface chemistry of the conjugate formation can be easily applied to other bioconjugation, such as leading to the formation of EG2-conjugated near-IR QDs which can be used for the early-stage diagnostics of cancers that express EGFR such as breast cancer.
CONCLUSIONS
We have successfully developed 2A3 single-domain antibody and explored targeted imaging of BxPC3 human pancreatic cancer cells with 2A3-conjugated near-IR CdTeSe/CdS QDs. Our successful targeted imaging, with high signal-to-background sensitivity and targeting specificity, demonstrates that sdAb-conjugated near-IR QDs enable great potential in the development of optical molecular imaging aiming at early-stage cancer detection. Further optimization on the synthesis of the targeted contrast agent is in progress, such as to increase the shell thickness of CdTeSe/CdS QDs, to improve colloidal stability in water via other hydrophilic compounds, such as the combination of PEGylation and sdAb conjugation.
